During the past decade, Helen Hayes Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Helen Hayes Hospital" #1 sponsor was "Health Research, Inc." with 2 trials, followed by "Helen Hayes Hospital" with 2 trials sponsored, "Acorda Therapeutics" with 1 trials sponsored, "Amgen" with 1 trials sponsored and "Columbia University" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Helen Hayes Hospital" #1 collaborator was "National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)" with 2 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 2 trials as a collaborator, "Health Research, Inc." with 1 trials as a collaborator, "Hospital for Special Surgery, New York" with 1 trials as a collaborator and "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Helen Hayes Hospital" are "Osteoporosis" (6 trials), "Stroke" (2 trials), "Hypertension" (1 trials), "Major Depression" (1 trials) and "Muscle Spasticity" (1 trials). Many other conditions were trialed in "Helen Hayes Hospital" in a lesser frequency.

Most popular intervention types in "Helen Hayes Hospital" are "Drug" (7 trials), "Behavioral" (2 trials), "Other" (2 trials), "Dietary Supplement" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Teriparatide" (2 trials), "placebo" (2 trials), "ALX1-11" (1 trials), "ALX1-11 50 mcg" (1 trials) and "ALX1-11 75mcg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Helen Hayes Hospital" are 8 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Helen Hayes Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Helen Hayes Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Helen Hayes Hospital, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 3 trials that are defined as “Not Applicable".